Category: Replacement Heart Valves
Edwards Lifesciences says the 1st 3 patients worldwide were implanted with its Fortis transcatheter mitral valve implant.
Edwards Lifesciences (NYSE:EW) said a surgical team at London's St. Thomas' Hospital implanted the 1st 3 patients with its Fortis transcatheter mitral valve implant.
The European Patent Office revokes an Edwards Lifesciences transcatheter aortic valve patent that has been the center of a long-running feud with Medtronic.
A study in the Annals of Internal Medicine finds that transcatheter aortic valve implants improve cardiovascular health but might not do as much for quality of life.
California's Claret Medical lands FDA approval to conduct a pivotal trial of its Sentinel cerebral blood clot defense system in patients undergoing transcatheter aortic valve replacement.
Claret Medical is clear to launch a pivotal U.S. trial of its Sentinel cerebral protection system, having won FDA approval to evaluate the device in patients undergoing transcatheter aortic valve implantation.
The study is slated to begin in the 1st quarter of 2014 and will involve up to 15 clinical centers, Claret reported.
Direct Flow Medical plans to use a newly acquired $50 million to commercialize its flagship transcatheter aortic valve implantation system.
California-based medtech company Direct Flow Medical landed $50 million in debt financing, planning on using the new funds to support commercialization of a new transcatheter aortic valve implantation system.
Medtronic asks a Delaware federal judge to overturn a $393 million patent infringement loss to Edwards Lifesciences over their respective replacement heart valves.
Transcatheter Technologies completes durability testing on its Trinity 3rd-generation transcatheter aortic valve implantation system, after putting the device through an estimated 15 years' worth of cycles.
German device maker Transcatheter Technologies GmbH said it finished durability-testing Trinity transcatheter aortic valve implantation system.
The company expects Trinity to be "the world's 1st 'truly repositionable'" replacement aortic valve. The device was put through 600 million cycles, or around 15 years, of durability testing by an independent lab, which reported that the device far exceeded minimum standards, according to a press release.